Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

-Reuters

December 14, 2022

1 minute read

-Reuters

Inogen Says On Dec. 19, Determined To Dispose Of Technology Intangible Assets Previously Acquired From New Aera Related To TAV Technology

December 22, 5:34 PM

-SEC Filing

September 23, 4:55 AM

Stephens & Co. analyst Joshua Long initiates coverage on Sysco (NYSE:SYY) with a Overweight rating and announces Price Target of $90.

November 14, 9:52 AM

AECOM (NYSE:ACM) reported fourth-quarter revenue growth of 2% year-over-year to $3.43 billion, missing the consensus of $3.52 billion. Net Service…

November 23, 5:34 AM

JP Morgan analyst Katherine Lei downgrades Noah Holdings (NYSE:NOAH) from Overweight to Neutral and lowers the price target from $24 to $15.